How To Create Interest And A Sense Of Urgency In An Outsourced Drug Development Model

Rob Wright, chief editor of Life Science Leader, conducted an executive virtual roundtable with Pamela Contag, Ph.D., cofounder and CEO of BioEclipse Therapeutics, a clinical-stage oncology company; and Dara Lockert, founder and executive director of Spannerwerks, a life science industry consultancy (view full video here). In this portion, Contag and Lockert share some of the practices used toward keeping outsourced partners excited and interested in the project, along with approaches used to create a sense of urgency. For more information on Contag’s approach to outsourcing, be sure to read, “A Small Biopharma’s View Of Working With CROs,” published in the July 2020 CRO Leadership Awards special supplement.